1. Drugs and biologics receiving FDA orphan drug designation: an analysis of the most frequently designated products and their repositioning strategies. (2nd December 2021) Authors: Miller, Kathleen L.; Kraft, Selma; Ipe, Abraham; Fermaglich, Lewis Journal: Expert opinion on orphan drugs Issue: Volume 9:Number 11/12(2021) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗